These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 7692607)

  • 21. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic colony-stimulating factors.
    Andreeff M; Welte K
    Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
    Mitsuyasu RT
    AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of the hematopoietic growth factors.
    Usha D; Thatte UM; Dahanukar SA
    J Postgrad Med; 1994; 40(4):210-5. PubMed ID: 9136242
    [No Abstract]   [Full Text] [Related]  

  • 26. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Nemunaitis JJ; Singer JW; Sanders JE
    Bone Marrow Transplant; 1991; 7 Suppl 3():24-7. PubMed ID: 1855082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic growth factors in cancer chemotherapy.
    Crawford J; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biology of the cytokine sequence cascade.
    Fraser JK; Lill MC; Figlin RA
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):2-8. PubMed ID: 8600544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
    Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 35. Hematopoietic growth factors for the treatment of inherited cytopenias.
    Zeidler C; Welte K
    Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM-CSF as an adjunct to autologous bone marrow transplantation.
    Gulati S; Bennett C; Phillips J; Van-Poznak C
    Stem Cells; 1993 Jan; 11(1):20-5. PubMed ID: 8457776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.
    Rabinowe SN; Nemunaitis J; Armitage J; Nadler LM
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):6-16. PubMed ID: 1712125
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
    Greenberg PL
    Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.